CN107312034A - 基于二亚胺配体的稀土金属配合物及其应用 - Google Patents

基于二亚胺配体的稀土金属配合物及其应用 Download PDF

Info

Publication number
CN107312034A
CN107312034A CN201710441715.4A CN201710441715A CN107312034A CN 107312034 A CN107312034 A CN 107312034A CN 201710441715 A CN201710441715 A CN 201710441715A CN 107312034 A CN107312034 A CN 107312034A
Authority
CN
China
Prior art keywords
alkyl
rare earth
chch
earth metal
metal complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710441715.4A
Other languages
English (en)
Other versions
CN107312034B (zh
Inventor
徐信
高红杰
苏健洪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou University
Original Assignee
Suzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou University filed Critical Suzhou University
Priority to CN201710441715.4A priority Critical patent/CN107312034B/zh
Publication of CN107312034A publication Critical patent/CN107312034A/zh
Application granted granted Critical
Publication of CN107312034B publication Critical patent/CN107312034B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/5045Complexes or chelates of phosphines with metallic compounds or metals
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/60Preparation of compounds containing amino groups bound to a carbon skeleton by condensation or addition reactions, e.g. Mannich reaction, addition of ammonia or amines to alkenes or to alkynes or addition of compounds containing an active hydrogen atom to Schiff's bases, quinone imines, or aziranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/0825Preparations of compounds not comprising Si-Si or Si-cyano linkages
    • C07F7/083Syntheses without formation of a Si-C bond
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0238Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
    • B01J2531/0241Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
    • B01J2531/0244Pincer-type complexes, i.e. consisting of a tridentate skeleton bound to a metal, e.g. by one to three metal-carbon sigma-bonds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/30Complexes comprising metals of Group III (IIIA or IIIB) as the central metal
    • B01J2531/35Scandium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Lubricants (AREA)

Abstract

本发明属于有机合成的技术领域。本发明的催化剂是基于二亚胺配体的稀土金属配合物。本发明还提供了该稀土金属催化剂在芳香胺氢胺烷基化反应中的应用。

Description

基于二亚胺配体的稀土金属配合物及其应用
技术领域
本发明属于化学技术领域,具体涉及一种催化剂的用途,尤其涉及稀土金属催化剂在芳香胺氢胺烷基化反应中的应用。
背景技术
芳香胺类化合物广泛存在于天然产物、药物、以及精细化学品中,是一类非常重要的化合物。通过简单芳香胺与烯烃发生氢胺烷基化反应可以高效的构建结构复杂的芳香胺类化合物,由于这是一类100%原子经济性的反应,所以受到人们的极大关注。目前这类反应主要采用第IV、V副族催化剂,且底物必须为伯胺或仲胺,且无法催化三级芳香胺的反应。
发明内容
本发明所要解决的技术问题是利用第III副族的稀土催化剂,高效催化了三级芳香胺的氢胺烷基化反应。
为了解决上述技术问题,本发明提供的技术方案为一种稀土催化剂:基于二亚胺配体的稀土金属配合物,其结构如式所示I:
上述结构式中,RE为Sc,Y及镧系金属,R1为C1-C4烷基,R2为氢或C1-C6烷基或(C1-C4烷基、C3-C6环烷基、芳基)取代的三价磷基,R3为C1-C6烷基,n为1-3,R4为与稀土成键的C1-C6烷基或[三(C1-C10烷基)]硅基取代的C1-C6烷基,表示共轭结构。
本发明优选的技术方案中,二亚胺配体的稀土金属配合物为基于二亚胺配体的稀土金属钪配合物L1,其结构式为式II
其中DIPP代表2,6-二异丙基苯基,表示配位键。
本发明式I的制备方法,包括如下步骤:
第一步:
在有机溶剂中和0℃-110℃下,由结构式为的β二酮与芳胺和芳胺在酸的催化作用下发生脱水缩合反应制得上述配体。或
在有机溶剂中和-78℃-110℃下,由结构式为的亚胺与结构为的亚胺锂盐反应制得上述配体。
第二步:
在有机溶剂中和-78℃-110℃下,由上述制得的配体与RE(R4)3反应生成稀土金属配合物(I),其中,R1为C1-C4烷基,R2为氢或C1-C6烷基或(C1-C4烷基、C3-C6环烷基、芳基)取代的三价磷基,R3为C1-C6烷基,n为1-3,R4为与稀土成键的C1-C6烷基或[三(C1-C10烷基)]硅基取代的C1-C6烷基,表示共轭结构。
本发明的基于二亚胺配体的稀土金属钪配合物L1式II的制备方法,包括如下步骤:
第一步:
0℃下,向结构为的亚胺锂盐的四氢呋喃溶液中滴加结构为的亚胺的四氢呋喃溶液,滴加完毕,30℃恒温搅拌过夜。反应完成后,抽干四氢呋喃,沉淀物依次用甲苯、己烷萃取,离心,收集上清液。上清液经抽干,己烷洗涤3次,抽干得浅黄色固体。
第二步:
将上述所得固体的甲苯溶液加入到Sc(CH2SiMe3)3(THF)2中,60℃反应4小时。反应完成后,抽干甲苯,己烷洗涤3次,抽干得黄色固体式II化合物,其中DIPP代表2,6-二异丙基苯基,表示配位键。
本发明第二方面提供结构式I的稀土催化剂的用途,用于催化如下的三级芳香胺与烯烃的氢胺烷基化反应,
上述反应中,R5为C1-C4烷基,R6为C1-C4烷基,R7为C1-C4烷基或C1-C4烷氧基或芳基或卤素F、Cl、Br、I,R8为氢或C1-C20烷基或C3-C10环烷基或芳基,R9为氢或C1-C20烷基或含烯基、炔基、烷氧基的C1-C20烷基或C3-C10环烷基或芳基或[三(C1-C10烷基)]硅基,R10为C1-C10烷基或C1-C10烷氧基或[三(C1-C10烷基)]硅基,R11为C1-C4烷基,为乙烯基或环烯基或环二烯基,n1为1-4,n2为1-4,n3为1-2,n4为1-4。
本发明优选的技术方案中,二亚胺配体的稀土金属配合物为基于二亚胺配体的稀土金属钪配合物L1,其结构式为式II:
其中DIPP代表2,6-二异丙基苯基,表示配位键。
本发明优选的技术方案中,共催化剂为[PhNHMe2][B(C6F5)4]、[Ph3C][B(C6F5)4]或者B(C6F5)3
本发明优选的技术方案中,所述稀土催化剂和共催化剂加入量分别为总反应物的10%mol。
本发明利用第III副族的稀土催化剂,首次实现了三级芳香胺与烯烃的氢胺烷基化反应,反应具有优异的化学选择性与区域选择性,且底物适用范围广。
具体实施方式
以下结合具体实施例对上述方案做进一步说明。应理解,这些实施例是用于说明本发明而不限于限制本发明的范围。实施例中采用的实施条件可以根据具体厂家的条件做进一步调整,未注明的实施条件通常为常规实验中的条件。
介绍和概述
本发明通过举例而非给出限制的方式来进行说明。应注意的是,在本公开文件中所述的“一”或“一种”实施方式未必是指同一种具体实施方式,而是指至少有一种。
下文将描述本发明的各个方面。然而,对于本领域中的技术人员显而易见的是,可根据本发明的仅一些或所有方面来实施本发明。为说明起见,本文给出具体的编号、材料和配置,以使人们能够透彻地理解本发明。然而,对于本领域中的技术人员将显而易见的是,本发明无需具体的细节即可实施。在其他例子中,为不使本发明费解而省略或简化了众所周知的特征。
将各种操作作为多个分立的步骤而依次进行描述,且以最有助于理解本发明的方式来说明;然而,不应将按次序的描述理解为暗示这些操作必然依赖于顺序。
将根据典型种类的反应物来说明各种实施方式。对于本领域中的技术人员将显而易见的是,本发明可使用任意数量的不同种类的反应物来实施,而不只是那些为说明目的而在这里给出的反应物。此外,也将显而易见的是,本发明并不局限于任何特定的混合示例。
实施例1:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入N,N-二甲基苯胺(86mg)及1-己烯(40mg),120℃加热10小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(89mg,91%yield)。
HRMS(ESI)m/z计算值:For C14H23N[M+H]+:206.1903;实测值:206.1909.
1H NMR(400MHz,C6D6,298K):δ=7.26(m,2H,m-Ph),6.78(m,1H,p-Ph),6.68(m,2H,o-Ph),3.00(dd,2JHH=14.5Hz,3JHH=6.6Hz,1H,CH2N),2.80(dd,2JHH=14.5Hz,3JHH=8.1Hz,1H,CH2N),2.63(s,3H,CH3N),1.78(m,1H,CHCH3),1.23(m,1H,CHCH2),1.23(m,1H,CH2),1.23(m,2H,CH2CH3),1.10(m,1H,CH2),0.93(m,1H,CHCH2),0.87(t,3JHH=6.9Hz,3H,CH2CH3),0.77(d,3JHH=6.7Hz,3H,CHCH3).
13C{1H}NMR(101MHz,C6D6,298K):δ=150.2(i-Ph),129.5(m-Ph),116.5(p-Ph),112.6(o-Ph),60.0(CH2N),39.3(CH3N),34.7(CHCH2),32.5(CHCH3),29.6(CH2),23.4(CH2CH3),17.9(CHCH3),14.3(CH2CH3)。
实施例2:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入N,N-二甲基苯胺(86mg)及1-癸烯(67mg),120℃加热22小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(100mg,80%yield)。
HRMS(ESI)m/z计算值:For C18H31N[M+H]+:262.2529;实测值:262.2536.
1H NMR(400MHz,C6D6,298K):δ=7.26(m,2H,m-Ph),6.78(m,1H,p-Ph),6.69(m,2H,o-Ph),3.02(dd,2JHH=14.5Hz,3JHH=6.7Hz,1H,CH2N),2.82(dd,2JHH=14.5Hz,3JHH=8.0Hz,1H,CH2N),2.64(s,3H,CH3N),1.82(m,1H,CHCH3),1.27(m,13H,CH2),0.99(m,1H,CHCH2),0.92(t,3JHH=6.8Hz,3H,CH2CH3),0.79(d,3JHH=6.7Hz,3H,CHCH3).
13C{1H}NMR(101MHz,C6D6,298K):δ=150.2(i-Ph),129.5(m-Ph),116.5(p-Ph),112.6(o-Ph),60.0(CH2N),39.4(CH3N),35.0(CHCH2),32.5(CHCH3),32.4(CH2),30.5(CH2),30.1(CH2),29.8(CH2),27.5(CH2),23.1(CH2CH3),17.9(CHCH3),14.4(CH2CH3)。
实施例3:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入N,N-二甲基苯胺(86mg)及烯丙基三甲基硅烷(54mg),120℃加热8小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(101mg,90%yield)。
HRMS(ESI)m/z计算值:For C14H25NSi[M+H]+:236.1829;实测值:236.1837.
1H NMR(400MHz,C6D6,298K):δ=7.26(m,2H,m-Ph),6.78(m,1H,p-Ph),6.70(m,2H,o-Ph),3.00(dd,2JHH=14.3Hz,3JHH=6.3Hz,1H,CH2N),2.80(dd,2JHH=14.3Hz,3JHH=8.5Hz,1H,CH2N),2.64(s,3H,CH3N),1.98(m,1H,CHCH3),0.83(d,3JHH=6.6Hz,3H,CHCH3),0.56(dd,2JHH=14.6Hz,4JHH=4.0Hz,1H,CH2SiMe3),0.21(dd,2JHH=14.6Hz,4JHH=9.8Hz,1H,CH2SiMe3),-0.01(s,9H,SiMe3).
13C{1H}NMR(101MHz,C6D6,298K):δ=150.3(i-Ph),129.5(m-Ph),116.6(p-Ph),112.6(o-Ph),62.9(CH2N),39.2(CH3N),29.2(CHCH3),22.4(CH2SiMe3),20.8(CHCH3),-0.5(SiMe3)。
实施例4:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入N,N-二甲基苯胺(86mg)及4-甲基-1-戊烯(40mg),120℃加热24小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(68mg,70%yield)。
HRMS(ESI)m/z计算值:For C14H23N[M+H]+:206.1903;实测值:206.1913.
1H NMR(400MHz,C6D6,298K):δ=7.26(m,2H,m-Ph),6.78(m,1H,p-Ph),6.69(m,2H,o-Ph),3.00(dd,2JHH=14.4Hz,3JHH=6.3Hz,1H,CH2N),2.76(dd,2JHH=14.5Hz,3JHH=8.3Hz,1H,CH2N),2.62(s,3H,CH3N),1.89(m,1H,CHCH3),1.54(m,1H,CHMe2),1.06(ddd,2JHH=13.7Hz,3JHH=8.9Hz,3JHH=4.9Hz,1H,CHCH2),0.90(m,1H,CHCH2,overlapped with CHCH3),0.86(d,3JHH=6.6Hz,3H,CHCH3),0.76(t,3JHH=6.4Hz,6H,CHMe2).
13C{1H}NMR(101MHz,C6D6,298K):δ=150.3(i-Ph),129.5(m-Ph),116.5(p-Ph),112.6(o-Ph),60.3(CH2N),44.5(CHCH2),39.3(CH3N),30.1(CHCH3),25.5(CHMe2),23.9(CHCH3),22.1,18.0(CHMe2)。
实施例5:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入N,N-二甲基-间甲基苯胺(96mg)及1-辛烯(53mg),120℃加热22小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(96mg,82%yield).
HRMS(ESI)m/z计算值:For C17H29N[M+H]+:248.2373;实测值:248.2384.
1H NMR(400MHz,C6D6,298K):7.21(m,1H,m-Ph),6.63(m,1H,p-Ph),6.58(m,2H,o-Ph),3.06(dd,2JHH=14.4Hz,3JHH=6.6Hz,1H,CH2N),2.85(dd,2JHH=14.4Hz,3JHH=8.1Hz,1H,CH2N),2.67(s,3H,CH3N),2.28(s,3H,PhCH3),1.85(m,1H,CHCH3),1.25(m,1H,CHCH2),1.25(m,6H,CH2),1.25(m,2H,CH2CH3),0.98(m,1H,CHCH2),0.91(t,3JHH=6.9Hz,3H,CH2CH3),0.81(d,3JHH=6.7Hz,3H,CHCH3).
13C{1H}NMR(101MHz,C6D6,298K):δ=150.4(i-Ph),138.6(m-Ph),129.4(m-Ph),117.5(p-Ph),113.4(o-Ph),110.1(o-Ph),60.0(CH2N),39.5(CH3N),35.0(CHCH2),32.5(CHCH3),32.3(CH2),30.1(CH2),27.4(CH2),23.1(CH2CH3),22.2(PhCH3),17.9(CHCH3),14.4(CH2CH3)。
实施例6:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入N,N,3,5-四甲基苯胺(106mg)及1-辛烯(53mg),120℃加热23小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(96mg,78%yield).
HRMS(ESI)m/z计算值:For C18H31N[M+H]+:262.2529;实测值:262.2525.
1H NMR(400MHz,C6D6,298K):δ=6.46(m,3H,o,p-Ph),3.10(dd,2JHH=14.4Hz,3JHH=6.6Hz,1H,CH2N),2.88(dd,2JHH=14.4Hz,3JHH=8.1Hz,1H,CH2N),2.71(s,3H,CH3N),2.29(s,6H,PhCH3),1.88(m,1H,CHCH3),1.27(m,1H,CHCH2),1.27(m,6H,CH2),1.27(m,1H,CH2CH3),1.00(m,1H,CHCH2),0.91(t,3JHH=6.9Hz,3H,CH2CH3),0.84(d,3JHH=6.7Hz,3H,CHCH3).
13C{1H}NMR(101MHz,C6D6,298K):δ=150.5(i-Ph),138.5(m-Ph),118.8(p-Ph),110.9(o-Ph),60.1(CH2N),39.6(CH3N),35.0(CHCH2),32.5(CHCH3),32.3(CH2),30.1(CH2),27.4(CH2),23.1(CH2CH3),22.1(PhCH3),18.0(CHCH3),14.4(CH2CH3)。
实施例7:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入5-(N,N-二甲胺基)-茚旦(115mg)及1-辛烯(53mg),120℃加热23小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(94mg,73%yield)。
HRMS(ESI)m/z计算值:For C19H31N[M+H]+:274.2529;实测值:274.2529.
1H NMR(400MHz,C6D6,298K):δ=7.17(m,1H,5-C9H9,overlapped with solvent),6.72(m,1H,2-C9H9),6.63(m,1H,6-C9H9),3.07(dd,2JHH=14.3Hz,3JHH=6.7Hz,1H,CH2N),2.88(dd,2JHH=14.6Hz,3JHH=8.3Hz,1H,CH2N),2.82(dd,2JHH=16.2Hz,3JHH=7.7Hz,4H,7-C9H9,9-C9H9),2.71(s,3H,CH3N),1.92(m,2H,8-C9H9),1.92(m,1H,CHCH3),1.27(m,1H,CHCH2),1.27(m,6H,CH2),1.27(m,2H,CH2CH3),1.00(m,1H,CHCH2),0.90(t,3JHH=6.9Hz,3H,CH2CH3),0.84(d,3JHH=6.7Hz,3H,CHCH3).
13C{1H}NMR(101MHz,C6D6,298K):δ=149.7(1-C9H9),145.2(3-C9H9),131.9(4-C9H9),125.0(5-C9H9),111.6(6-C9H9),109.2(2-C9H9),60.7(CH2N),39.9(CH3N),35.1(CHCH2),33.9(7-C9H9),32.5(CHCH3),32.4(9-C9H9),32.3(CH2),30.1(CH2),27.5(CH2),26.3(8-C9H9),23.1(CH2CH3),18.0(CHCH3),14.4(CH2CH3)。
实施例8:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入N,N-二甲基苯胺(86mg)及烯丙基苯(56mg),120℃加热8小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(89mg,78%yield)。
HRMS(ESI)m/z计算值:For C17H21N[M+H]+:240.1747;实测值:240.1760.
1H NMR(400MHz,C6D6,298K):δ=7.25(m,2H,m-PhN),7.14(m,2H,m-Ph),7.07(m,1H,p-Ph),6.98(m,2H,o-Ph),6.79(m,1H,p-PhN),6.63(m,2H,o-PhN),3.02(dd,2JHH=14.5Hz,3JHH=6.1Hz,1H,CH2N),2.79(dd,2JHH=14.5Hz,3JHH=7.6Hz,1H,CH2N),2.58(s,3H,CH3N),2.54(m,1H,PhCH2),2.08(m,1H,PhCH2),2.08(m,1H,CHCH3),0.71(d,3JHH=6.3Hz,3H,CHCH3).
13C{1H}NMR(101MHz,C6D6,298K):δ=150.1(i-PhN),141.1(i-Ph),129.5(m-PhN),129.4(o-Ph),128.6(m-Ph),126.2(p-Ph),116.6(p-PhN),112.6(o-PhN),59.4(CH2N),41.5(PhCH2),39.3(CH3N),34.7(CHCH3),17.7(CHCH3)。
实施例9:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入N,N-二甲基苯胺(86mg)及1-烯丙基萘(80mg),120℃加热48小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(117mg,85%yield)。
HRMS(ESI)m/z计算值:For C21H23N[M+H]+:290.1903;实测值:290.1911.
1H NMR(400MHz,C6D6,298K):δ=7.87(m,1H,6-C10H7),7.68(m,1H,7-C10H7),7.59(d,3JHH=8.2Hz,1H,4-C10H7),7.24(m,1H,3-C10H7),7.24(m,1H,5-C10H7),7.24(m,1H,8-C10H7),7.24(m,2H,m-Ph),7.12(m,1H,2-C10H7),6.79(m,1H,p-Ph),6.63(m,2H,o-Ph),3.17(dd,2JHH=13.3Hz,3JHH=4.6Hz,1H,CHCH2),3.00(dd,2JHH=14.5Hz,3JHH=7.4Hz,1H,CH2N),2.97(dd,2JHH=14.5Hz,3JHH=7.2Hz,1H,CH2N),2.62(s,3H,CH3N),2.41(dd,2JHH=13.3Hz,3JHH=9.4Hz,1H,CHCH2),2.29(m,1H,CHCH3),0.69(d,3JHH=6.5Hz,3H,CHCH3).
13C{1H}NMR(101MHz,C6D6,298K):δ=150.0(i-Ph),137.3(1-C10H7),134.6(10-C10H7),132.6(9-C10H7),129.5(m-Ph),129.2(7-C10H7),127.5(2-C10H7),127.2(4-C10H7),126.0(5-C10H7),125.7(3-C10H7),125.5(8-C10H7),124.4(6-C10H7),116.7(p-Ph),112.8(o-Ph),60.0(CH2N),39.6(CH3N),38.6(CHCH2),33.8(CHCH3),18.0(CHCH3)。
实施例10:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入4-二甲氨基联苯(141mg)及1-辛烯(53mg),120℃加热45小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(99mg,67%yield)。
HRMS(ESI)m/z计算值:For C22H31N[M+H]+:310.2529;实测值:310.2525.
1H NMR(400MHz,C6D6,298K):δ=7.63(m,2H,o-Ph),7.58(m,2H,m-PhN),7.29(m,2H,m-Ph),7.13(m,1H,p-Ph),6.72(m,2H,o-PhN),3.04(dd,2JHH=14.5Hz,3JHH=6.6Hz,1H,CH2N),2.84(dd,2JHH=14.5Hz,3JHH=8.1Hz,1H,CH2N),2.66(s,3H,CH3N),1.83(m,1H,CHCH3),1.26(m,1H,CHCH2),1.26((m,6H,CH2),1.26(m,2H,CH2CH3),0.98(m,1H,CHCH2),0.91(t,3JHH=6.8Hz,3H,CH2CH3),0.81(d,3JHH=6.7Hz,3H,CHCH3).
13C{1H}NMR(101MHz,C6D6,298K):δ=149.5(i-PhN),142.1(i-Ph),129.3(p-PhN),129.1
(m-Ph),128.2(m-PhN),126.7(o-Ph),126.2(p-Ph),112.8(o-PhN),59.8(CH2N),39.4(CH3N),35.0(CHCH2),32.5(CHCH3),32.3(CH2),30.1(CH2),27.4(CH2),23.1(CH2CH3),17.9(CHCH3),14.4(CH2CH3)。
实施例11:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入N,N-二甲基苯胺(86mg)及乙烯基环己烷(52mg),120℃加热21小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(100mg,91%yield)。
HRMS(ESI)m/z计算值:For C16H25N[M+H]+:232.2060;实测值:232.2071.
1H NMR(400MHz,C6D6,298K):δ=7.28(m,2H,m-Ph),6.79(m,1H,p-Ph),6.71(m,2H,o-Ph),3.15(dd,2JHH=14.5Hz,3JHH=5.9Hz,1H,CH2N),2.80(dd,2JHH=14.5Hz,3JHH=9.0Hz,1H,CH2N),2.63(s,3H,CH3N),1.67(m,1H,CHCH3),1.67(m,3H,C6H11),1.48(m,2H,C6H11),1.13(m,3H,C6H11),1.02(m,1H,C6H11),0.92(m,2H,C6H11),0.74(d,3JHH=6.9Hz,3H,CHCH3).
13C{1H}NMR(101MHz,C6D6,298K):δ=150.2(i-Ph),129.5(m-Ph),116.4(p-Ph),112.6(o-Ph),57.4(CH2N),41.0(C6H11),31.3(C6H11),28.6(C6H11),27.3(C6H11),27.1(C6H11),27.0(C6H11),39.4(CH3N),37.2(CHCH3),14.3(CHCH3)。
实施例12:
称取L1(35mg),[PhNHMe2][B(C6F5)4](38mg),溶于甲苯中,室温反应8小时。反应完成,加入N,N-二甲基-1-萘胺(122mg)及1-辛烯(53mg),120℃加热76小时。反应完成后,抽干甲苯得油状残渣,经柱色谱分离得浅黄色油状液体(51mg,38%yield)。
HRMS(ESI)m/z计算值:For C20H29N[M+H]+:284.2373;实测值:284.2384.
1H NMR(400MHz,C6D6,298K):δ=8.52(m,1H,3-C10H7),7.70(m,1H,2-C10H7),7.47(m,1H,7-C10H7),7.40(m,1H,4-C10H7),7.30(m,1H,6-C10H7),7.30(m,1H,8-C10H7),7.04(m,1H,5-C10H7),2.89(dd,2JHH=12.3Hz,3JHH=6.6Hz,1H,CH2N),2.74(dd,2JHH=12.3Hz,3JHH=8.0Hz,1H,CH2N),2.64(s,3H,CH3N),1.75(m,1H,CHCH3),1.49(m,1H,CHCH2),1.24(m,2H,CH2CH3),1.24(m,6H,CH2),1.09(m,1H,CHCH2),0.97(d,3JHH=6.6Hz,3H,CHCH3),0.90(t,3JHH=6.7Hz,3H,CH2CH3).
13C{1H}NMR(101MHz,C6D6,298K):δ=151.4(1-C10H7),135.6(10-C10H7),130.8(9-C10H7),128.7(2-C10H7),126.1(6-C10H7),126.0(8-C10H7),125.5(4-C10H7),124.5(3-C10H7),123.8(7-C10H7),116.6(5-C10H7),63.3(CH2N),44.4(CH3N),35.4(CHCH2),32.3(CH2),30.1(CH2),27.3(CH2),31.6(CHCH3),23.1(CH2CH3),18.4(CHCH3),14.4(CH2CH3)。
以上所述具体实施例仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进或替换,这些改进或替换也应当视为本发明的保护范围。

Claims (6)

1.基于二亚胺配体的稀土金属配合物,其特征在于,其结构如式所示I:
上述结构式中,RE为Sc,Y及镧系金属,R1为C1-C4烷基,R2为氢或C1-C6烷基或(C1-C4烷基、C3-C6环烷基、芳基)取代的三价磷基,R3为C1-C6烷基,n为1-3,R4为与稀土成键的C1-C6烷基或[三(C1-C10烷基)]硅基取代的C1-C6烷基,表示共轭结构。
2.根据权利要求1所述的基于二亚胺配体的稀土金属配合物,其特征在于,所述二亚胺配体的稀土金属配合物为基于二亚胺配体的稀土金属钪配合物L1,其结构式为式II:
其中DIPP代表2,6-二异丙基苯基,表示配位键。
3.如权利要求1所述的结构式I的稀土催化剂的用途,用于催化如下的三级芳香胺与烯烃的氢胺烷基化反应,
上述反应中,R5为C1-C4烷基,R6为C1-C4烷基,R7为C1-C4烷基或C1-C4烷氧基或芳基或卤素F、Cl、Br、I,R8为氢或C1-C20烷基或C3-C10环烷基或芳基,R9为氢或C1-C20烷基或含烯基、炔基、烷氧基的C1-C20烷基或C3-C10环烷基或芳基或[三(C1-C10烷基)]硅基,R10为C1-C10烷基或C1-C10烷氧基或[三(C1-C10烷基)]硅基,R11为C1-C4烷基,为乙烯基或环烯基或环二烯基,n1为1-4,n2为1-4,n3为1-2,n4为1-4。
4.根据权利要求3所述的用途,其特征在于,所述二亚胺配体的稀土金属配合物为基于二亚胺配体的稀土金属钪配合物L1,其结构式为式II:
其中DIPP代表2,6-二异丙基苯基,表示配位键。
5.根据权利要求3所述的用途,其特征在于,共催化剂为[PhNHMe2][B(C6F5)4]、[Ph3C][B(C6F5)4]或者B(C6F5)3
6.根据权利要求3所述的用途,其特征在于,所述稀土催化剂和共催化剂加入量分别为总反应物的10%mol。
CN201710441715.4A 2017-06-13 2017-06-13 基于二亚胺配体的稀土金属配合物及其应用 Active CN107312034B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710441715.4A CN107312034B (zh) 2017-06-13 2017-06-13 基于二亚胺配体的稀土金属配合物及其应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710441715.4A CN107312034B (zh) 2017-06-13 2017-06-13 基于二亚胺配体的稀土金属配合物及其应用

Publications (2)

Publication Number Publication Date
CN107312034A true CN107312034A (zh) 2017-11-03
CN107312034B CN107312034B (zh) 2019-05-10

Family

ID=60183182

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710441715.4A Active CN107312034B (zh) 2017-06-13 2017-06-13 基于二亚胺配体的稀土金属配合物及其应用

Country Status (1)

Country Link
CN (1) CN107312034B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109851507A (zh) * 2019-01-23 2019-06-07 苏州大学 含钪稀土催化剂在催化芳香胺对位烷基化反应中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106478717A (zh) * 2016-09-27 2017-03-08 苏州大学 含三齿nnp配体的稀土金属受阻路易斯酸碱对的合成及其应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106478717A (zh) * 2016-09-27 2017-03-08 苏州大学 含三齿nnp配体的稀土金属受阻路易斯酸碱对的合成及其应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FRANK LAUTERWASSER ET AL: "Scandium-Catalyzed Intramolecular Hydroamination. Development of a Highly Active Cationic Catalyst", 《ORGANOMETALLICS》 *
赵立立: "STN检索记录", 《STN检索记录 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109851507A (zh) * 2019-01-23 2019-06-07 苏州大学 含钪稀土催化剂在催化芳香胺对位烷基化反应中的应用
CN109851507B (zh) * 2019-01-23 2022-02-01 苏州大学 含钪稀土催化剂在催化芳香胺对位烷基化反应中的应用

Also Published As

Publication number Publication date
CN107312034B (zh) 2019-05-10

Similar Documents

Publication Publication Date Title
TWI473654B (zh) 作為矽氫化催化劑之含三牙基氮配位體之金屬錯合物之原位活化
Du et al. Tuning silver (I) coordination architectures by ligands design: from dinuclear, trinuclear, to 1D and 3D frameworks
Lyubov et al. N, N ‘-Diisopropyl-N ‘‘-bis (trimethylsilyl) guanidinate Ligand as a Supporting Coordination Environment in Yttrium Chemistry. Synthesis, Structure, and Properties of Complexes [(Me3Si) 2NC (N i-Pr) 2] YCl2 (THF) 2,[(Me3Si) 2NC (N i-Pr) 2] Y (CH2SiMe3) 2 (THF) 2, and [(Me3Si) 2NC (N i-Pr) 2] Y [(μ-H)(μ-Et) 2BEt] 2 (THF)
CN109942638A (zh) 用于乙烯聚合的含邻位二对甲基苯甲基取代的不对称α-二亚胺镍(Ⅱ)配合物
CN107312034B (zh) 基于二亚胺配体的稀土金属配合物及其应用
CN109651445A (zh) 一种大位阻三价铑亚胺配合物的制备及其应用
Xu et al. Single, double and triple deprotonation of a β-diketimine bearing pendant pyridyl group and the corresponding rare-earth metal complexes
Li et al. Reaction of 1-(dimethylsilyl)-2-silylbenzene with platinum (0) phosphine complex: Isolation and characterization of the Si3–PtIV–H complex
CN104817583B (zh) 碳桥联双酰胺基稀土胺化物及其制备和在催化醛与胺酰胺化合成反应中的应用
Sato et al. Asymmetric Synthesis of N‐(Diphenylphosphinyl) amines Promoted by Chiral Carbosilane Dendritic Ligands in The Enantioselective Addition of Dialkylzinc Compounds to N‐(Diphenylphosphinyl) imines
JPH0517487A (ja) 新規シラン化合物及びその製造方法
Böker et al. Halides of Ortho-Substituted Arylaluminum Compounds with Coordination Numbers Four and Five
CN1302025C (zh) 一种西佛碱配位ivb族的烯烃聚合催化剂及其制备方法和应用
CN101220058B (zh) 手性和非手性pcn钳形钯化合物及合成方法和用途
JPH04288087A (ja) 4−エトキシフェニル−3−アリールプロピル(ジメチル)シランの製造方法
JP5886876B2 (ja) 新規な(トリオルガノシリル)アルキン及びその誘導体、並びに、新規な及び慣用の置換(トリオルガノシリル)アルキンと、その誘導体を得るための新規な触媒法
CN117510430B (zh) 一种噁唑类化合物及其合成方法与应用
CN107459530A (zh) 一种新型硅基取代的1,3‑异喹啉二酮衍生物及其制备方法
CN108641022A (zh) 稀土催化剂及其制备方法以及苯乙烯间规聚合方法
CN115340475B (zh) 一种1-氧化二苯基二氮烯或其衍生物的制备方法
CN101863743A (zh) 4,4’-亚甲基双(2,6-二甲基)苯酚的制备方法
CN107602337A (zh) 一种1,4‑二氰基‑2‑丁烯的制备方法
Sausa et al. Synthesis and crystal structures of 5, 5′-(propane-2, 2-diyl) bis (2-hydroxybenzaldehyde) and 5, 5′-(propane-2, 2-diyl) bis (2-hydroxyisophthalaldehyde)
Rehn et al. Synthesis of Allylamines fromAlkynes and Iminium Ions
US20100222601A1 (en) Synthesis of cyclopentadiene derivatives

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant